Science & Technology
Fy2025 Sbir Concept Clearance Award for Topic Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers and/or Rare Cancers.
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N91025C00012
Award Ceiling
$353K
Award Floor
$353K
Close Date
N/A
Total Funding
$353K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N91025C00012
Description
SBIR Phase Phase I award: "FY2025 SBIR CONCEPT CLEARANCE AWARD FOR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS." awarded to Tenaci-T Therapeutics LLC in Missouri City, Texas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $352,621. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.